Jeff Auxier's DGX Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 25,451 shares of Quest Diagnostics Incorporated (DGX) worth $4.99 M, representing 0.72% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in DGX, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 50,500 shares. Largest reduction occurred in Q4 2016, reducing 15,535 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Quest Diagnostics Incorporated (DGX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Quest Diagnostics Incorporated (DGX) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -460 | Reduce 1.78% | 25,451 | $195.98 |
| Q4 2025 | -387 | Reduce 1.47% | 25,911 | $173.53 |
| Q3 2025 | -479 | Reduce 1.79% | 26,298 | $190.58 |
| Q2 2025 | -125 | Reduce 0.46% | 26,777 | $179.63 |
| Q1 2025 | -675 | Reduce 2.45% | 26,902 | $169.20 |
| Q4 2024 | -628 | Reduce 2.23% | 27,577 | $150.86 |
| Q3 2024 | -10 | Reduce 0.04% | 28,205 | $155.25 |
| Q1 2024 | -85 | Reduce 0.30% | 28,215 | $133.11 |
| Q4 2023 | -75 | Reduce 0.26% | 28,300 | $137.88 |
| Q3 2023 | -90 | Reduce 0.32% | 28,375 | $121.86 |
| Q1 2023 | -2,400 | Reduce 7.78% | 28,465 | $141.48 |
| Q4 2022 | -232 | Reduce 0.75% | 30,865 | $156.44 |
| Q3 2022 | -213 | Reduce 0.68% | 31,097 | $122.68 |
| Q2 2022 | -15 | Reduce 0.05% | 31,310 | $132.99 |
| Q1 2022 | -2,655 | Reduce 7.81% | 31,325 | $136.86 |
| Q4 2021 | -1,800 | Reduce 5.03% | 33,980 | $173.01 |
| Q3 2021 | -1,100 | Reduce 2.98% | 35,780 | $145.30 |
| Q2 2021 | -60 | Reduce 0.16% | 36,880 | $131.97 |
| Q1 2021 | -25 | Reduce 0.07% | 36,940 | $128.34 |
| Q4 2020 | -30 | Reduce 0.08% | 36,965 | $119.17 |
| Q3 2020 | -50 | Reduce 0.13% | 36,995 | $114.50 |
| Q1 2020 | -1,000 | Reduce 2.63% | 37,045 | $80.31 |
| Q3 2019 | -1,025 | Reduce 2.62% | 38,045 | $107.03 |
| Q2 2019 | -200 | Reduce 0.51% | 39,070 | $101.82 |
| Q4 2018 | -150 | Reduce 0.38% | 39,270 | $83.27 |
| Q3 2018 | -1,000 | Reduce 2.47% | 39,420 | $107.91 |
| Q1 2018 | -2,175 | Reduce 5.11% | 40,420 | $100.30 |
| Q3 2017 | -50 | Reduce 0.12% | 42,595 | $93.65 |
| Q2 2017 | -3,200 | Reduce 6.98% | 42,645 | $111.15 |
| Q1 2017 | -8,150 | Reduce 15.09% | 45,845 | $98.20 |
| Q4 2016 | -15,535 | Reduce 22.34% | 53,995 | $91.90 |
| Q3 2016 | -425 | Reduce 0.61% | 69,530 | $84.63 |
| Q1 2016 | -315 | Reduce 0.45% | 69,955 | $71.45 |
| Q4 2015 | -2,550 | Reduce 3.50% | 70,270 | $71.14 |
| Q3 2015 | -150 | Reduce 0.21% | 72,820 | $61.47 |
| Q2 2015 | -50 | Reduce 0.07% | 72,970 | $72.52 |
| Q1 2015 | -1,780 | Reduce 2.38% | 73,020 | $76.86 |
| Q4 2014 | -4,150 | Reduce 5.26% | 74,800 | $67.06 |
| Q3 2014 | -50 | Reduce 0.06% | 78,950 | $60.68 |
| Q2 2014 | -1,350 | Reduce 1.68% | 79,000 | $58.70 |
| Q4 2013 | +19,300 | Add 31.61% | 80,350 | $53.54 |
| Q3 2013 | +50,500 | Add 478.67% | 61,050 | $61.79 |
| Q2 2013 | +10,551 | Add 0.00% | 10,550 | $60.66 |
Jeff Auxier's Quest Diagnostics Incorporated Investment FAQs
Jeff Auxier first purchased Quest Diagnostics Incorporated (DGX) in Q2 2013, acquiring 10,550 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Quest Diagnostics Incorporated (DGX) for 52 quarters since Q2 2013.
Jeff Auxier's largest addition to Quest Diagnostics Incorporated (DGX) was in Q3 2013, adding 61,050 shares worth $3.77 M.
According to the latest 13F filing for Q1 2026, Jeff Auxier's firm, Auxier Asset Management LLC, owns 25,451 shares of Quest Diagnostics Incorporated (DGX), valued at approximately $4.99 M.
As of the Q1 2026 filing, Quest Diagnostics Incorporated (DGX) represents approximately 0.72% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Quest Diagnostics Incorporated (DGX) was 80,350 shares, as reported at the end of Q4 2013.